Denileukin diftitox-cxdl 0.3 MG Injection — RxCUI 2700750
RxNorm drug concept · Semantic clinical drug
RxCUI 2700750
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2700750
Official nameDenileukin diftitox-cxdl 0.3 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdenileukin diftitox-cxdl 300 MCG Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Denileukin Diftitox Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- LYMPHIR targets a specific type of skin lymphoma called cutaneous T-cell lymphoma (CTCL) — a cancer that starts in immune cells and shows up mainly on the skin. It's used when the...
- What exactly is this drug treating, and why was I given it instead of something else?
- No, LYMPHIR is given by IV infusion in a clinic or infusion center — not at home as a pill or injection you self-administer. You'll come in for 5 consecutive days, receive a 60-min...
- How is this given — do I take it at home?
🕸️ Concept Web — How Denileukin diftitox-cxdl 0.3 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Denileukin diftitox-cxdl 0.3 MG Injection
RxCUI 2700750 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Denileukin diftitox
214470IN -
Denileukin diftitox-cxdl
2700746PIN
-
Denileukin diftitox
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lymphir
2700751BN
-
Lymphir
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Denileukin diftitox Injection
1807475SCDF -
Denileukin diftitox-cxdl Injection
2700749SCDFP -
Denileukin diftitox Injectable Product
1157741SCDG -
Denileukin diftitox-cxdl Injectable Product
2700748SCDGP -
Denileukin diftitox Injection [Lymphir]
2700754SBDF -
Denileukin diftitox-cxdl Injection [Lymphir]
2700755SBDFP -
Lymphir Injectable Product
2700753SBDG -
Injection
1649574DF - +1 more in this family
-
Denileukin diftitox Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Denileukin diftitox-cxdl 0.3 MG
2700747SCDC -
Denileukin diftitox-cxdl 0.3 MG Injection [Lymphir]
2700756SBD -
Denileukin diftitox-cxdl 0.3 MG [Lymphir]
2700752SBDC
-
Denileukin diftitox-cxdl 0.3 MG
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Denileukin diftitox-cxdl 0.3 MG
SCDC · 2700747 -
Denileukin diftitox Injection
SCDF · 1807475 -
Denileukin diftitox-cxdl Injection
SCDFP · 2700749 -
Denileukin diftitox Injectable Product
SCDG · 1157741 -
Denileukin diftitox-cxdl Injectable Product
SCDGP · 2700748
Brand-Name Concepts
-
Denileukin diftitox-cxdl 0.3 MG Injection [Lymphir]
SBD · 2700756 -
Denileukin diftitox-cxdl 0.3 MG [Lymphir]
SBDC · 2700752 -
Denileukin diftitox Injection [Lymphir]
SBDF · 2700754 -
Denileukin diftitox-cxdl Injection [Lymphir]
SBDFP · 2700755 -
Lymphir Injectable Product
SBDG · 2700753 -
Lymphir
BN · 2700751
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2700750 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 52658-7777-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (52658-7777-1) / 2 mL in 1... | LYMPHIR | Citius Pharmaceuticals, Inc. | 2025-03-01 |
Observed labelers:
Citius Pharmaceuticals, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9161 | Inj denileuk difti-cxdl 1mcg | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.